Upcoming Events | Past Events
Q3 2018 Adaptimmune Earnings Conference Call
Tuesday, November 6, 2018 8:00 a.m. ET

Adaptimmune at Leerink Partners Roundtable Series: Rare Disease & Oncology
Wednesday, October 3, 2018 1:30 p.m. ET
LocationLotte New York Palace
455 Madison Avenue
New York, NY 10022

Adaptimmune at Morgan Stanley 16th Annual Global Healthcare Conference
Wednesday, September 12, 2018 9:20 a.m. ET
DescriptionFireside Chat At Morgan Stanley 16th Annual Global Healthcare Conference (Grand Hyatt NYC Salon1) on 12 Sept @ 9:20am EDT / 2:20 UK with James Noble (CEO), Gwen Binder (CTO), and Adrian Rawcliffe (CFO) with webcast here: http://bit.ly/2CgF9VJ .

Q2 2018 Adaptimmune Earnings Conference Call
Thursday, August 2, 2018 8:00 a.m. ET
Description

The press release and the live webcast of the conference call will be available in the investor section of Adaptimmune’s corporate website at www.adaptimmune.com. An archive will be available after the call at the same address.

To participate in the live conference call, if preferred, please dial (833) 652-5917 (U.S.) or (430) 775-1624 (International). After placing the call, please ask to be joined into the Adaptimmune conference call and provide the confirmation code (8149978).


Adaptimmune to discuss updated data from 2018 ASCO annual meeting
Monday, June 4, 2018 8:00 a.m. ET

Q1 2018 Financial Results and Business Update
Wednesday, May 9, 2018 8:00 a.m. ET

Adaptimmune at the 6th annual Alliance for Regenerative Medicine (ARM) Cell & Gene Therapy Investor Day
Tuesday, April 17, 2018 11:40 a.m. ET
Description
  • 10:25 AM - Panel I: Technology Trends: Leading Platforms Acrosss The Cell And Gene Sector
  • 11:40 AM - Company presentation in the West Lounge Room
LocationMetropolitan Club
One East 60th Street
New York, NY 10022

Adaptimmune to Present Two Posters at American Association for Cancer Research (AACR) Annual Meeting
Monday, April 16, 2018 1:00 p.m. CT
Description

Session, date, time, and location (for both posters):

  • Session Category (Title): Clinical Research (Adoptive Cell Therapy 2)
  • Date: Monday Apr 16, 2018
  • Time: 1:00 PM - 5:00 PM (CDT)
  • Location: McCormick Place South, Exhibit Hall A, Poster Section 24

Poster 1 – MAGE-A4

  • Title: Affinity-enhanced T-cell receptor (TCR) for adoptive T-cell therapy targeting MAGE-A4
  • Poster Board Number: 21
  • Permanent Abstract Number: 2562

Poster 2 – MAGE-A10

  • Title: Selection of affinity-enhanced T-cell receptors for adoptive T-cell therapy targeting MAGE‑A10
  • Poster Board Number: 23
  • Permanent Abstract Number: 2564

Adaptimmune will also have a booth (#3700) in the Exhibit Hall.


Adaptimmune Reports Fourth Quarter / Full Year 2017 Financial Results and Business Update
Thursday, March 15, 2018 8:00 a.m. ET

Adaptimmune at Cowen 38th Annual Health Care Conference
Tuesday, March 13, 2018 11:20 a.m. ET
DescriptionAdaptimmune to give company overview at Cowen 38th Annual Health Care Conference at the Boston Marriot Copley Plaza on Tuesday March 13th at 11.20 to 11.50 AM (EDT) in Suffolk third floor followed by a breakout session in Wellesley third floor from 12.00 to 12.30pm.
LocationBoston Marriot Copley Plaza

Adaptimmune at Raymond James 39th Annual Institutional Investor’s Conference
Tuesday, March 6, 2018 11:00 a.m. ET
Locationthe J.W. Marriot Grande Lakes
Orlando, FL

Adaptimmune at LEERINK Partners 7th Annual Global Healthcare Conference
Wednesday, February 14, 2018 3:30 p.m. ET

Adaptimmune at American Society of Hematology (ASH) Annual Meeting Confirm NY-ESO SPEAR T-cell Efficacy in Multiple Myeloma Pilot Study
Monday, December 11, 2017 5:30 p.m. ET
Description

Oral Presentation 845: Phase I/IIa Study of Genetically Engineered NY-ESO-1 SPEAR T-Cells Administered Following Autologous Stem Cell Transplant in HLA-a*02+ Patients with Advanced Multiple Myeloma: Long Term Follow‑up (NCT01352286)

Session: 703. Adoptive Immunotherapy: Gene Engineered T cells for Hematologic Malignancies

Time: Monday, December 11, 2017: 5:30 PM (EST)

Location: Bldg. B, Level 2, B206 (Georgia World Congress Center)

Result highlights from the abstract include:

  • Overall response rate (ORR) at day 100 was 76% (1 stringent complete response [sCR]; 12 very good partial response [VGPR]; 6 partial response [PR])
  • At year 1, 13 patients were progression free (52%) of which 11 were responders (1 sCR; 1 CR; 8 VGPR; 1 PR)
  • Three patients remain disease progression-free at 39, 56, and 61 months post T-cell infusion
  • Median progression free survival (PFS) was ~13 months (range 3-61 months)
  • Eleven of 25 patients (44%) are alive, and median survival was ~35 months (range 6-68 months)
  • Autologous GvHD (24%) was reported in 6 patients (3 G3, 3 ≤G2); all resolved with corticosteroids and supportive therapy
  • No fatal adverse events have been reported
LocationBldg. B, Level 2, B206 (Georgia World Congress Center)

2017 SITC Annual Meeting
Wednesday, November 8, 2017 through Sunday, November 12, 2017
Description

Trials in Progress Posters:

  • Title: Study Design: Phase 1 dose escalation, multi-tumor study to assess safety, tolerability and antitumor activity of genetically engineered MAGE-A4 SPEAR T-cells in HLA-A2+ subjects with MAGE-A4+ tumors
    -   Poster Number: P247
    -   Session Time: November 10, 2017 from 12:30 PM to 2:00 PM (lunch) and 6:30 PM to 8:00 PM (reception)
    -   Location: Prince George’s Exhibition Hall DE

  • Title: Study Design:  An Open-label Randomized Pilot Study of NY-ESO-1 SPEAR T-cells Alone or in Combination with Pembrolizumab in HLA-A2+ Subjects with Relapsed and Refractory Multiple Myeloma (NCT03168438)
    -   Poster Number: P248
    -   Session Time: November 11, 2017 from 12:30 PM to 2:00 PM (lunch) and 6:30 PM to 8:00 (reception)
LocationGaylord National Hotel & Convention Center
National Harbor, MD

Q3 2017 Adaptimmune Earnings Conference Call
Thursday, November 2, 2017 8:00 a.m. ET

Adaptimmune at Leerink Partners Roundtable Series: Rare Disease and Immuno-oncology
Thursday, September 28, 2017 10:30 a.m. ET

Adaptimmune at Cell and Gene Therapy CEO Conference
Monday, September 25, 2017 9:15 a.m. through Monday, September 25, 2017 9:45 a.m. ET
DescriptionJames Noble (CEO) is speaking on the panel “2017 Industry Outlook: What's Driving Development in Cell & Gene Therapies”
LocationFour Seasons Hotel
Boston, MA

GSK Exercises Option over SPEAR T-cell Therapy Program Targeting NY-ESO
Thursday, September 7, 2017 8:30 a.m. ET

Adaptimmune at Citi’s 12th Annual Biotech Conference
Wednesday, September 6, 2017
DescriptionJames Noble (CEO), Adrian Rawcliffe (CFO), and Juli Miller (Director IR) to attend.
LocationMandarin Oriental Hotel
Boston

CAR-T Summit in Boston
Tuesday, September 5, 2017 through Wednesday, September 6, 2017
Description

Pre-Summit Deep Dive Day, Tuesday, September 5

Session G, 3:00-5:00pm, Understanding and Overcoming the Tumor Microenvironment, Samik Basu, Director Adaptimmune Translational Science Research

Summit Day 1, Wednesday, September 6

8:45-10:00am, Industry Leaders’ Fireside Chat, James Noble, Adaptimmune Chief Executive Officer

11:50am-12:20pm, Building a commercial Engineered T-Cell Therapy Strategy, Helen Tayton-Martin, Adaptimmune Chief Business Officer

2:25-2:55pm, Applying Lifecylce Concepts to Advanced Stage T Cell Therapy Product Development, Michael Blackton

LocationSeaport Hotel & World Trade Center
One Seaport Lane
Boston, MA 02210

Adaptimmune Data Update on NY-ESO SPEAR T-cells in Synovial Sarcoma; ASCO 2017
Tuesday, June 6, 2017 8:00 a.m. ET
Description

Live PARTICIPANT Dial-In (Toll-Free US & Canada): 866-405-1247
Live PARTICIPANT Dial-In (International):  201-689-8045


Q1 2017 Adaptimmune Earnings Conference Call
Wednesday, May 10, 2017 8:00 a.m. ET

Adaptimmune at Deutsche Bank 42nd Annual Health Care Conference
Thursday, May 4, 2017 1:10 p.m. ET
LocationInterContinental Boston Hotel
Boston, MA

Q4 2016 Adaptimmune Earnings Conference Call
Monday, March 13, 2017 8:00 a.m. ET

Adaptimmune at Cowen and Company 37th Annual Health Care Conference
Tuesday, March 7, 2017 10:40 a.m. ET

Adaptimmune at LEERINK Partners 6th Annual Global Healthcare Conference
Wednesday, February 15, 2017 1:00 p.m. ET

Adaptimmune to Present Three Posters at the 31st Annual Meeting of the Society for Immunotherapy for Cancer (SITC)
Friday, November 11, 2016 through Saturday, November 12, 2016
Description

Friday, November 11, 2016
Poster Presentation 
Poster number: 3
Title: “Preclinical evaluation of an optimal-affinity MAGE-A4 T cell receptor for adoptive T cell therapy”
Presentation Time: 12:15 – 1:30pm 
Location: Prince George's Exhibition Hall AB

This presentation will summarize the preclinical profile for our wholly-owned SPEAR T-cell therapy targeting the MAGE-A4 cancer-germline antigen.

Friday, November 11, 2016
Poster Presentation 
Poster number: 5
Title: “Engineering 2nd Generation SPEAR T-cells to overcome FACTOR-mediated immunosuppression for adoptive cell therapy”
Presentation Time: 12:15 – 1:30pm 
Location: Prince George's Exhibition Hall AB

This presentation will summarize preclinical data from Adaptimmune’s first, 2nd generation SPEAR T-cell designed to overcome tumor immunosuppression by expressing an additional factor (which will be announced the day of the presentation).

Saturday, November 12, 2016
Poster Presentation
Poster number: 4
Title: “Case Report: Specific Peptide Enhanced Affinity Receptor T-cells (SPEAR T-cells) demonstrate long-term persistence and both in vivo and ex vivo tumoricidal activity”
Presentation Time: 11:45 – 1:00pm 
Location: Prince George's Exhibition Hall AB

Data presented will be from a single-patient case study from the ongoing synovial sarcoma trial. SPEAR T-cells were profiled and phenotyped during this patient’s treatment.


Q3 2016 Adaptimmune Earnings Conference Call
Thursday, November 10, 2016 8:00 a.m. ET

Adaptimmune at Leerink Partners Roundtable Series: Rare Disease and Immuno-Oncology
Thursday, September 29, 2016 8:30 a.m. ET

Adaptimmune at 2016 Morgan Stanley Global Healthcare Conference
Tuesday, September 13, 2016 8:00 a.m. ET

Q2 2016 Adaptimmune Earnings Conference Call
Monday, August 8, 2016 8:00 a.m. ET

Adaptimmune at JMP Securities 2016 Life Sciences Conference
Tuesday, June 21, 2016 10:30 a.m. ET

Adaptimmune at Jefferies 2016 Healthcare Conference
Wednesday, June 8, 2016 4:30 p.m. ET

Adaptimmune at 2016 UBS Global Healthcare Conference
Tuesday, May 24, 2016 10:30 a.m. ET
Supporting Materials
Download Event Supporting Material ADAP Presentation May 2016

Adaptimmune at Bank of America Merrill Lynch 2016 Health Care Conference
Tuesday, May 10, 2016 11:20 a.m. PT

Adaptimmune at Deutsche Bank 41st Annual Health Care Conference
Wednesday, May 4, 2016 8:40 a.m. ET

2016 Adaptimmune Analyst and Investor Day
Friday, April 22, 2016 8:30 a.m. ET
Supporting Materials
Download Event Supporting Material 2016 Adaptimmune Analyst and Investor Day

Adaptimmune at Cowen and Company 36th Annual Health Care Conference
Monday, March 7, 2016 4:40 p.m. ET

Adaptimmune at RBC Capital Markets
Wednesday, February 24, 2016 11:00 a.m. ET

Adaptimmune at LEERINK Partners 5th Annual Global Healthcare Conference
Wednesday, February 10, 2016 8:25 a.m. ET

Adaptimmune at 2016 BIO CEO & Investor Conference
Tuesday, February 9, 2016 9:00 a.m. ET

Adaptimmune to Discuss Expansion of Strategic Collaboration Agreement with GlaxoSmithKline (GSK)
Tuesday, February 2, 2016 10:00 a.m. ET

Adaptimmune at Jefferies 2015 London Healthcare Conference
Wednesday, November 18, 2015 11:20 a.m. GMT

Adaptimmune at 2015 Annual Meeting of SITC
Friday, November 6, 2015 12:45 p.m. ET

Adaptimmune at 14th Annual BIO Investor Forum
Tuesday, October 20, 2015 9:00 a.m. PT

Q4 2015 Adaptimmune Earnings Conference Call
Tuesday, October 13, 2015 8:00 a.m. ET

Adaptimmune at Leerink Partners Inaugural Immuno-Oncology Roundtable
Thursday, October 1, 2015 2:20 p.m. ET

Adaptimmune at 2015 Morgan Stanley Global Healthcare Conference
Thursday, September 17, 2015 4:05 p.m. ET

Adaptimmune at 2015 Bank of America Merrill Lynch Global Healthcare Conference
Thursday, September 17, 2015 4:00 a.m. ET

Adaptimmune at BioCentury's 22nd Annual NewsMakers in the BioTech Industry Conference
Thursday, September 10, 2015 11:30 a.m. ET

2015 Wedbush PacGrow Healthcare Conference
Tuesday, August 11, 2015 9:45 a.m. ET

Archived Corporate Events

Immunology 2015, The AAI Annual Meeting
8th to 12th May 2015
New Orleans, USA

American Society of Gene and Cell Therapy (ASGCT)
13th to 16th May 2015
New Orleans, USA

Cell Symposium; Cancer Inflammation and Immunity
14th to 16th June 2015
Sitges, Spain